The use of medical Cannabis has increased in recent years due to changing legal
circumstances in many countries. Approval exists only for a few neurological conditions such …

Context Studies generally focus on one type of chronic condition and the effect of medical
cannabis (MC) on symptoms; little is known about the perceptions and engagement of …

2.2. Study design This study is an online, randomized, delayed start trial of the effectiveness
of eCBT for PD patients with depressive symptoms. N= 120 PD patients with depressive …

Cannabis (in all the varied methods of delivery) continues to garner significant attention as a
potential therapeutic intervention for neurodegenerative disorders, including Parkinson's …

Background: Natural health products have emerged as a potential symptomatic therapeutic
approach for people with Parkinson's disease (PD). Objective: To determine the prevalence …

Natural health products (NHP) have emerged as a potential symptomatic therapeutic
approach for persons with Parkinson's disease (PwP). The objective of this study was to …

Parkinson's disease (PD) is a neurodegenerative pathology on the rise worldwide. There is
a demand for new therapeutic options that contribute to more quality of life and autonomy for …

Parkinson's disease is a slowly progressive, degenerative disorder characterized by resting
tremors, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually …

Background: Public opinion and policy changes are redefining the use of cannabis. Most
recently cannabis use is on the rise in the aging population as it is being introduced as a …

This randomized, double-blind, placebo-controlled trial involving 61 participants examined
the short-term efficacy and tolerability of a high cannabidiol (CBD) and low Δ-9 …